Organon & Co. (OGN) has a consensus analyst rating of Buy, based on 8 analysts covering the stock. Of those, 3 recommend buying, 2 recommend holding, and 3 recommend selling.
The analyst consensus price target for OGN is $6.50, representing a -25.3% downside from the current price of $8.7. Price targets range from a low of $5.00 to a high of $8.00.
